Two variants of Interleukin-1B gene are associated with the decreased risk, clinical features, and better overall survival of colorectal cancer: a two-center case-control study
Figure 1.TCGA data confirmed the IL-1B expressions in rectal cancer patients were significantly higher than in the control, which was analyzed by GEPIA. T: tumor samples; N: paired normal tissues.